Taltz

• Brands Taltz
• Product Code: Taltz

• Taltz works by binding to IL-17A, inhibiting its interaction with the IL-17 receptor. This action reduces the release of proinflammatory cytokines and chemokines, thereby decreasing inflammation associated with autoimmune conditions .Indications

  Taltz is indicated for the treatment of

  • Plaque Psoriasis: Adults and children aged 6 years and older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

  • Psoriatic Arthritis: Adults with active psoriatic arthritis.

  • Ankylosing Spondylitis: Adults with active ankylosing spondylitis.

  • Non-radiographic Axial Spondyloarthritis: Adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation .

  Administration & Dosing

  Taltz is administered as a subcutaneous injection. The dosing schedule varies based on the condition being treated

  • Plaque Psoriasis:

    • 160 mg at Week 0 (two 80 mg injections), followed by 80 mg at Weeks 2, 4, 6, 8, 10, and 12, then 80 mg every 4 weeks thereafter.

  • Psoriatic Arthritis:

    • 160 mg at Week 0 (two 80 mg injections), followed by 80 mg every 4 weeks thereafter .

  • Ankylosing Spondylitis:

    • 160 mg at Week 0 (two 80 mg injections), followed by 80 mg every 4 weeks thereafter 

  • Non-radiographic Axial Spondyloarthritis:

    • 80 mg every 4 weeks

  Side Effects

  Common side effects of Taltz include:

  • Upper respiratory infections

  • Injection site reactions

  • Headache

  • Fatigue

  • Diarrhea

  • Nausea

  Serious side effects may include:

  • Increased risk of infections

  • Allergic reactions

  • Elevated blood pressure

  • Changes in liver function tests

  Patients should be monitored for signs of infection and other potential adverse effects during treatment .

• Availability: In Stock

• American Diabetes Association

• Diabetes Disaster_Response Coalition storing insulin

• FDA Approved Prescription